These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1043)

  • 21. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of oxypertine in anxiety conditions].
    Somohano MD; Broissin MC; Sobrino Z A
    Neurol Neurocir Psiquiatr; 1976; 17(3):171-80. PubMed ID: 12484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical assessment of lorazepam in anxiety: a double-blind study.
    Olgiati SG
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative efficacy of propranolol, chlordiazepoxide, and placebo in the treatment of anxiety: a double-blind trial.
    Meibach RC; Dunner D; Wilson LG; Ishiki D; Dager SR
    J Clin Psychiatry; 1987 Sep; 48(9):355-8. PubMed ID: 3305488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of phospholipid liposomes in the treatment of neuropsychological disorders associated with the menopause: a double-blind, randomised, placebo-controlled study.
    Rachev E; Nalbansky B; Kolarov G; Agrosì M
    Curr Med Res Opin; 2001; 17(2):105-10. PubMed ID: 11759177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U; Kieser M
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
    Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug.
    Fischer-Cornelssen KA
    Arzneimittelforschung; 1981; 31(10):1757-65. PubMed ID: 6119092
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of the Benzodiazepine-derivative Ro 06-9098/000 on choreo-athetotic syndromes (author's transl)].
    Girke W; Lieske V
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):281-5. PubMed ID: 30103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The significance of standardized evaluation scales in psychiatric diagnosis as exemplified by the therapeutic intervention with desmethyl-loxapine (author's transl)].
    Bergener M; Escher HD; Linden KJ
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):69-81. PubMed ID: 788003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of Wittenborn psychiatric rating scales in geriatric psychiatry. Results of a double blind study with cyprodenate and placebo].
    Bergener M; Freistein H
    Arzneimittelforschung; 1972 Dec; 22(12):2058-63. PubMed ID: 4575344
    [No Abstract]   [Full Text] [Related]  

  • 36. [An ocular toxicity study with flupirtine as an example of evaluation of possible ocular drug side effects in human volunteers (author's transl)].
    Koch HR; Kremer F; Trier HG; Marzinkowski A
    Klin Monbl Augenheilkd; 1982 Jan; 180(1):70-4. PubMed ID: 7043066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Incidence of anonymous medication before admission to the hospital (author's transl)].
    Linde OK
    Pharmakopsychiatr Neuropsychopharmakol; 1979 May; 12(3):286-90. PubMed ID: 39303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The "paired cards" system. A practical and generally applicable procedure for the clinical trial of drugs (author's transl)].
    Schenck EG; Kirchert W
    Arzneimittelforschung; 1978; 28(1a):192. PubMed ID: 580218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [RIDIT-analysis: a non-parametric test for comparing distributions (author's transl)].
    Basler HD
    Methods Inf Med; 1974 Jan; 13(1):48-53. PubMed ID: 4596905
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the conformation of unsymmetrically substituted 1,4-benzodiazepin-2-ones (author's transl)].
    Sadée W; Schwandt HJ; Beyer KH
    Arch Pharm (Weinheim); 1973 Oct; 306(10):751-6. PubMed ID: 4773838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.